+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 164 Pages
  • Global
From
HIV Drugs Market Report 2025 - Product Thumbnail Image

HIV Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Region, 2025-2033 - Product Thumbnail Image

HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Region, 2025-2033

  • Report
  • June 2025
  • 138 Pages
  • Global
From
North America HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Country, 2025-2033 - Product Thumbnail Image

North America HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Country, 2025-2033

  • Report
  • August 2025
  • 122 Pages
  • North America
From
Long-acting Anti-HIV Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Long-acting Anti-HIV Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2025 - Product Thumbnail Image

Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HIV Drugs Market Size Analysis Report - Market Share, Forecast Trends and Outlook 2025-2034 - Product Thumbnail Image

HIV Drugs Market Size Analysis Report - Market Share, Forecast Trends and Outlook 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
HIV Drugs: Market Share, and Growth Analysis by Product Type (NRTIs, NNRTIs, PIs, Integrase Inhibitors), Application, End User, Technology - Product Thumbnail Image

HIV Drugs: Market Share, and Growth Analysis by Product Type (NRTIs, NNRTIs, PIs, Integrase Inhibitors), Application, End User, Technology

  • Report
  • August 2025
  • 150 Pages
  • Global
From
HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030 - Product Thumbnail Image

HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030

  • Report
  • February 2025
  • 274 Pages
  • Global
From
HIV Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Sponsor, By Region, And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

HIV Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Sponsor, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • November 2024
  • 120 Pages
  • Global
From
Etravirine Market - Global Forecast to 2030 - Product Thumbnail Image

Etravirine Market - Global Forecast to 2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Anti-Retroviral Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Anti-Retroviral Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 192 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Human Immunodeficiency Virus Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 199 Pages
  • Global
From
HIV Clinical Trials Market - Global Forecast 2025-2032 - Product Thumbnail Image

HIV Clinical Trials Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
HIV Vaccines Market - Global Forecast 2025-2032 - Product Thumbnail Image

HIV Vaccines Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 187 Pages
  • Global
From
Lamivudine Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lamivudine Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Enfuvirtide for Injection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Enfuvirtide for Injection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Injectable HIV Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Injectable HIV Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast to 2030 - Product Thumbnail Image

Tenofovir Disoproxil Fumarate Tablets Market - Global Forecast to 2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Ubenimex Capsules Market - Global Forecast 2025-2030 - Product Thumbnail Image

Ubenimex Capsules Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more